. . . . . . . . . . . . "bp(GO:\"response to oxidative stress\") -| p(RGD:Serpina1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "alpha(1)-Macroglobulin (Pzp) and alpha(1)-protease inhibitor gradually decreased during the whole study period, probably being second line defense inhibitors." . . "Selventa" . . . . "2014-07-03T14:29:47.762+02:00"^^ . . .